GENE

Name: GENE FDA catalyst calendar
Creator: Pharmaconomics

Regeneron Pharmaceuticals

2 catalysts on file

GENE

Regeneron Pharmaceuticals

Phase 2 Estimated

Alirocumab

Hypercholesterolemia

T-minus 175 days Dec 29, 2026

ClinicalTrials.gov verified 15h ago

GENE

Regeneron Pharmaceuticals

Phase 2 Estimated

REGN5668

Ovarian Cancer

T-minus 261 days Mar 25, 2027

ClinicalTrials.gov verified 15h ago